Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Clinical Data moves to broaden European presence
March 2006
SHARING OPTIONS:

NEWTON, Mass.óClinical Data, a global provider of comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care, has purchased GENOME express, a genomics services company based in the Rhone-Alpes region of France with headquarters in Meylan, France.
Under terms of the agreement, GENOME express shareholders received total consideration of 2.65 million euros (approximately $3.16 million). Of this amount, 200,000 euros (approximately $238,000) is being paid in cash and the remainder is being paid through the issuance of 123,179 shares of Clinical Data common stock.
 "GENOME express is a leading genomics services company. In France, GENOME express is unsurpassed in the scope and breadth of its platform and its capacity for proprietary genomics, transcription, and proteomics analysis as well as its bio-computing backbone," notes Clinical Data's President and CEO Dr. Israel M. Stein. "The company has substantial operations and a strong track record of providing value to European and international pharmaceutical companies and biotechs. The services offered by GENOME express are very complementary and additive to those currently being provided by Clinical Data's COGENICS division. This transaction should also be accretive to earnings over the relatively near term."
"From both a financial and product perspective, and in terms of GENOME express' geographic reach and client base of over 2,000 active customers, this acquisition provides Clinical Data with an ideal opportunity to support additional European initiatives," Stein adds. "Expansion beyond our present U.K. operations, where we already have a substantial presence, and into Europe by leveraging GENOME express assets and capabilities, provides the core strategic rationale for this transaction."
GENOME express CEO Warren Barton, says, "We welcome the opportunity to become a part of Clinical Data. We see this transaction as the initial phase of a strategic opportunity to jointly capitalize on the huge growth potential in genomics and related services in Europe. As a combined company, we anticipate building a substantial competitive advantage driven by the ability to offer the most comprehensive suite of genomics services to clients."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.